Piper Jaffray Downgrades Corcept Therapeutics (CORT) to Neutral

Article Stock Quotes (1) Comments (0)

Piper Jaffray downgraded Corcept Therapeutics (NASDAQ: CORT) from Overweight to Neutral with a price target of $3.00 (from $5.00).

For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.

Shares of Corcept Therapeutics closed at $2.81 yesterday, with a 52 week range of $2.50-$4.90.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
• Susquehanna Downgrades Universal Health Services (UHS) to Neutral
• UPDATE: Macquarie Downgrades Barrick Gold (ABX) to Underperform

Create E-mail Alert Related Categories

Analyst PT Change, Downgrades

Related Entities

Piper Jaffray

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?